Life sciences organizations launched a wave of innovation, from new treatment modalities to advanced analytics and digital connectivity to help so many people get through the pandemic. Now as these same companies emerge from disruption to face new global and industry pressures, leaders are asking “what next” to drive value and profitability. 

 

Rising to the challenge, life sciences leaders are looking to do the impossible again and their vision is fixed on technology. Getting the greatest value from cloud and digital is vital, but the potential of artificial intelligence (AI) – and especially generative AI – is enormous for life sciences. But where should you start?